CVS Health (NYSE: CVS) reported Q4 EPS of $2.12, $0.14 better than the analyst estimate of $1.98. Revenue for the quarter came in at $93.81 billion versus the consensus estimate of $90.25 billion.

GUIDANCE:

CVS Health sees FY2024 EPS of at least $8.30, versus its prior view of at least $8.50 and the consensus of $8.50.

For earnings history and earnings-related data on CVS Health (CVS) click here.